J Barandela Salgado

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The management of gastrointestinal stromal tumors, usually defined as c-KIT-positive mesenchymal neoplasias, has evolved very rapidly in the last five years. Imatinib mesylate (Glivec(R)) is the(More)
  • 1